Company news
Nanoecho Ab (OMXSTO:NANECH) news
Nanoecho Ab news releases on 6ix. Latest, Jun 17, 2026: NanoEcho PoC Study Does Not Meet Primary Endpoint
Press releases & updates
NanoEcho PoC Study Does Not Meet Primary Endpoint
June 17, 2026
NanoEcho Appoints Fata Mrsic As CFO
June 12, 2026
Nanoecho Elects Micael Wikberg As Chairman
May 28, 2026
Nanoecho Q1 2026 Net Sales Amount To 0 Tsek
April 30, 2026
Nanoecho Receives Decision To Grant Design-Related Patent In US
April 22, 2026
Investors Announce That They Do Not Intend To Fulfill Subscription Commitments In Nanoecho's Recently Completed Rights Issue
March 17, 2026
Nanoecho Plans To Update Application To EIC Accelerator
March 11, 2026
NanoEcho Announces Rights Issue Results, Updates Business Plan
March 3, 2026
NanoEcho Enters Deal With Professor Tomas Jansson At Lund University
February 25, 2026
Nanoecho Q4 Net Sales Of SEK 0
February 12, 2026
Nanoecho Announces Rights Issue To Raise About SEK 20.5 Mln
February 4, 2026
NanoEcho Approved To Start Recruitment For POC Study
January 28, 2026
Nanoecho Signs LoI With Henrik Thorlacius For Clinical Studies
January 12, 2026
Nanoecho Announces LOI With Renowned Surgeon Prof. Susan Moug
December 23, 2025
Nanoecho Elects Björn Larsson As Chairman Of The Board
December 9, 2025
Nanoecho Receives Approval For Diagnostic Equipment In Study
December 2, 2025
NanoEcho Gets Approval For NEP-01 In Proof Of Concept Study
November 28, 2025
NanoEcho AB (publ) receives observation status
October 27, 2025
Nanoecho Q3 Net Sales Amounted To SEK 488.000
October 23, 2025
Nanoecho Gets SEK 0.3 Mln Funding From Vinnova
October 10, 2025
Nanoecho Adjusts Diagnostic System UI After Study Feedback
October 9, 2025
NanoEcho AB: Quarterly Trading Report 2025 Q3
October 3, 2025
NANECH: Clinical milestones reached, losses narrowed, and first revenues expected soon
August 21, 2025
NANECH: Clinical milestone achieved and financial base strengthened for rectal cancer diagnostics
April 30, 2025
NANECH: Clinical progress, new financing, and IPO recognition mark NanoEcho's pivotal year
February 13, 2025
NANECH: Strong equity and clinical progress position NanoEcho for future commercialization
October 25, 2024
NANECH: Product development finalized, ISO certified, and clinical phase initiated after successful financing
August 23, 2024